Michael A. Panzara - Feb 16, 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Medical Officer, Head of Therapeutics Discovery and Development
Signature
/s/ Michael A. Panzara
Stock symbol
WVE
Transactions as of
Feb 16, 2022
Transactions value $
-$24,493
Form type
4
Date filed
2/18/2022, 05:00 PM
Previous filing
Jan 4, 2022
Next filing
Mar 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Sale -$24.5K -10.6K -12.27% $2.31 75.8K Feb 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 16, 2022, the reporting person sold 10,603 ordinary shares solely to cover taxes associated with the vesting of restricted share units ("RSUs") on February 15, 2022. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
F2 The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $2.31 to $2.38 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

Chief Medical Officer, Head of Therapeutics Discovery and Development